Biopharmaceutical issues including: social and economic, value of the biopharmaceutical sector, patient access and safety issues, drug importation, life science innovation, and job impact.
2025 · 4th Quarter (Oct 1 - Dec 31)
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Filed by BRAVO GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- $40,000.00
- Expenses
- Not reported
- Registrant
- BRAVO GROUP
- Filing UUID
- f0106d10-8d87-4d9b-b1cc-25cfa048c4a7
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.